MAMohamed Aboubakr

Mohamed Aboubakr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohamed Aboubakr has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmed Soliman

    Pharmacology Department, Faculty of veterinary Medicine, Cairo University, Giza, Egypt

    1 shared publication
  • Ashraf Elkomy

    Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt

    1 shared publication
  • Asmaa Elsayed

    Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt

    1 shared publication
  • Ehab Yahya Abdelhiee

    Forensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, Matrouh University, Matrouh, Egypt

    1 shared publication
  • Gehan Youssef

    Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt

    1 shared publication
  • Reda Elkammar

    Department of Histology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats

    by Asmaa Elsayed, Ashraf Elkomy, Reda Elkammar, Gehan Youssef, Ehab Yahya Abdelhiee, Walied Abdo, Sabreen Ezzat Fadl, Ahmed Soliman, Mohamed Aboubakr

    Cisplatin (CP) is one of the most frequently used chemotherapy agents. The objective of this design was to determine the ameliorative effect of lycopene (LP) and/or N-acetylcysteine (NAC) in rats with hepatic and renal toxicity induced by CP. Rats were divided randomly into 7 groups (7 rats/group): control vehicle group (saline only), the LP group (10 mg/kg, orally), the NAC group (150 mg/kg, orally), the CP group (7.5 mg/kg, IP on day 27), the LP-CP group, the NAC-CP group, and the LP-NAC-CP group. The activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (APK), and levels of urea, creatinine, and lipids (cholesterol, triglycerides, and low-density lipoprotein-cholesterol) increased after CP injection in the serum. Moreover, CP decreased levels of protein, albumin, and HDL cholesterol. Meanwhile, malondialdehyde significantly increased with a decrease in reduced glutathione, superoxide dismutase, and catalase in the liver and kidney tissues. CP also induced some pathological lesions and increased the expression of caspase-3 in the liver and kidney tissues. Administration of LP and NAC alone or in combinations ameliorated hepatorenal toxicity and apoptosis induced by CP.